Bajaj Healthcare Ltd - Stock Valuation and Financial Performance

BSE: 539872 | NSE: BAJAJHCARE | Pharmaceuticals & Drugs | Small Cap

Bajaj Healthcare Share Price

385.15 -7.00 -1.79%
as on 21-Nov'24 16:59

DeciZen - make an informed investing decision on Bajaj Healthcare

Overall Rating
Bole Toh

1. Quality

2. Valuation

Somewhat overvalued

3. Price Trend

Semi Strong

Bajaj Healthcare stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
1,238.5 Cr.
52-wk low:
265
52-wk high:
428.4

Is Bajaj Healthcare Ltd an attractive stock to invest in?

1. Is Bajaj Healthcare Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Bajaj Healthcare Ltd is a good quality company.

2. Is Bajaj Healthcare Ltd undervalued or overvalued?

The key valuation ratios of Bajaj Healthcare Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Bajaj Healthcare Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Bajaj Healthcare Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Bajaj Healthcare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bajaj Healthcare Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 19.2%18%14.5%18.3%19.8%19.5%35.9%20%14%1.9%-
Value Creation
Index
0.40.30.00.30.40.41.60.40-0.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 197200207290325410657680646473508
Sales YoY Gr.-1.5%3.5%39.7%12.3%26.2%60.2%3.5%-5%-26.7%-
Adj EPS 2.83.22.356.59.42926.422.84-3.2
YoY Gr.-12.7%-28.1%118.7%28.8%44.9%208.7%-9.1%-13.5%-82.6%-
BVPS (₹) 13.817.235.926.432.264.593.6119133.2100.9141.2
Adj Net
Profit
7.78.76.413.917.925.98072.76310.9-10
Cash Flow from Ops. 27.925.122.116.625.220.643.60.7-22.292.3-
Debt/CF from Ops. 2.53.23.45.23.24.44.2374.3-18.73.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 10.2%7.8%-10.4%-26.7%
Adj EPS 3.8%-9.4%-48.5%-82.6%
BVPS24.7%25.7%2.5%-24.3%
Share Price - 33.9% 5.3% 0.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
13.510.26.813.114.816.936.724.818.13.4-2.6
Op. Profit
Mgn %
14.715.514.913.61412.520.817.717.316.116.7
Net Profit
Mgn %
3.94.33.14.85.56.312.210.79.82.3-2
Debt to
Equity
1.81.80.81.20.90.50.70.81.11.20.1
Working Cap
Days
137128133124128131115173126173145
Cash Conv.
Cycle
6667695863664989426533

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years -10.35%

Debt to equity has increased versus last 3 years average to 1.19

Sales growth is not so good in last 4 quarters at 0.56%

Latest Financials - Bajaj Healthcare Ltd.

Standalone Consolidated
TTM EPS (₹) -3.2 -
TTM Sales (₹ Cr.) 508 -
BVPS (₹.) 141.2 -
Reserves (₹ Cr.) 430 -
P/BV 2.78 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 265.00 / 428.35
All Time Low / High (₹) 42.50 / 511.90
Market Cap (₹ Cr.) 1,239
Equity (₹ Cr.) 15.8
Face Value (₹) 5
Industry PE 43

Management X-Ray of Bajaj Healthcare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Bajaj Healthcare

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales197200207290325410657680646473
Operating Expenses 168170176250282362521561534397
Manufacturing Costs36373741475389927270
Material Costs111106111178197263378406383255
Employee Cost 14172022252835414244
Other Costs 71099141819223728
Operating Profit 29303139434813611911176
Operating Profit Margin (%) 14.6%15.0%14.9%13.6%13.2%11.8%20.8%17.5%17.3%16.1%
Other Income 0022177129
Interest 8888878131830
Depreciation 991111111216181728
Exceptional Items 000000000-44
Profit Before Tax 1213142324361199078-17
Tax 5567811361815-2
Profit After Tax 888151625837164-14
PAT Margin (%) 3.8%4.1%3.8%5.2%5.0%6.2%12.7%10.5%9.8%-3.0%
Adjusted EPS (₹)2.83.02.85.55.99.130.125.923.0-5.2
Dividend Payout Ratio (%)0%0%0%5%0%0%5%6%4%-19%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 828999114129178258328368278
Share Capital 477771414141414
Reserves 788292107122164245315354265
Minority Interest0000000000
Debt607466767282168243383300
Long Term Debt22312721172480669439
Short Term Debt37423955555888176289261
Trade Payables231619433057691058589
Others Liabilities 24303535352630456475
Total Liabilities 189209219268267343526721899743

Fixed Assets

Gross Block162191200210222268329402525423
Accumulated Depreciation5362728394106121132159170
Net Fixed Assets108130128127128162208270366253
CWIP 1102155752227
Investments 0000050000
Inventories18201734303997159209144
Trade Receivables52435380789899185194180
Cash Equivalents 101884142193
Others Assets91521172128505490157
Total Assets 189209219268267343526721899743

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 282522172521441-2292
PBT 1213142324361199058-104
Adjustment 171719192016243156170
Changes in Working Capital -0-0-6-19-6-22-64-111-12539
Tax Paid -1-5-5-6-13-9-36-10-12-13
Cash Flow From Investing Activity -17-31-8-12-13-28-109-75-93-11
Capex -18-30-10-10-15-18-62-79-93-19
Net Investments 00000-55007
Others 201-22-4-52401
Cash Flow From Financing Activity -115-132-1337562131-97
Net Proceeds from Shares 0030000000
Net Proceeds from Borrowing 89-5-5-4656-1245-24
Interest Paid -8-8-8-8-8-6-8-13-23-42
Dividend Paid 0000-10-2-1-4-3
Others -113-315043088113-28
Net Cash Flow 00070-410-1216-16
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)22.3819.610.7717.6820.1818.9238.0924.3318.25-4.44
ROCE (%)19.161814.5218.2519.7519.4735.912014.021.88
Asset Turnover Ratio1.311.121.081.341.381.341.511.091.591.15
PAT to CFO Conversion(x)3.53.132.751.131.560.840.530.01-0.34N/A
Working Capital Days
Receivable Days89777674787955765472
Inventory Days35312928313138695268
Payable Days886757646861617890125

Bajaj Healthcare Ltd Stock News

Bajaj Healthcare Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Bajaj Healthcare on 21-Nov-2024 16:59 is ₹385.1.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Bajaj Healthcare stood at ₹1,238.5.
The latest P/E ratio of Bajaj Healthcare as of 21-Nov-2024 16:59 is 0.00.
The latest P/B ratio of Bajaj Healthcare as of 21-Nov-2024 16:59 is 2.78.
The 52-week high of Bajaj Healthcare is ₹428.4 and the 52-week low is ₹265.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bajaj Healthcare is ₹507.8 ( Cr.) .

About Bajaj Healthcare Ltd

The company was incorporated as Bajaj Healthcare Private Limited on July 15, 1993 under the Companies Act, 1956, with the Registrar of Companies, Mumbai bearing Registration Number - 072892. The status of the company was changed to a public limited company and the name of the company was changed to Bajaj Healthcare Limited by a special resolution passed on March 15, 2005. A fresh certificate of incorporation consequent to the change of name was granted to the company on March 31, 2005, by the Registrar of Companies, Mumbai. The company began its operations in the year 1993 with an API manufacturing unit in Tarapur, near Mumbai. Over the years it has expanded its scale and scope of operations and currently it operates five manufacturing units for manufacture of APIs, Intermediates and Formulations.

The company’s present product portfolio consists of various APIs in the therapeutic categories of Neutraceutical (Amino Acids), Vitamins, Anti-Convulsants, Bactericidal & Bacteriostatic, Diuretic & Vasodilator, Mineral & Nutritional supplements, Bronchodilater / Anti-asthmatic and Nootropics. The company’s Formulations unit manufactures tablets, capsules and sachets for its own brands as well as under Loan License (job work) for other pharmaceutical companies. Currently, the company manufactures formulations for GlaxoSmithKline Pharmaceuticals (GSK) and USV (USV) on a Loan License basis. The formulations manufactured for its own brands are manufactured and marketed under a separate division of Bajaj Medicare and it also has marketing tie-up with TTK Healthcare. The FDFs manufactured by it covers various therapeutic segments like Antibiotics, Anti-Arrhythmia, Anti-Convulsants, Anti-Diabetes, Anti-Platelets, NSAIDs, Vitamins & its Derivatives, Anti-Hypertensive, Anti-Bacterial, Anti-Malarial, Cholinesterase Inhibitors, etc.

With the combined production of its API facilities and that of its Formulation unit, the company’s product portfolio consists of APIs and FDFs which shall be marketed in domestic and international markets as branded generics. Presently it is supplying its APIs and FDFs both domestically and exporting to various countries in regions like, Europe, USA, Australia, Africa, South America, etc. With its long standing operations and quality products, the company has built a strong relationship with its customers for both APIs and FDFs. Some of its major clients include nationally and internationally known pharmaceutical companies like Glaxo Smithkline Consumer Healthcare, Ava Inc., Abbott Healthcare, Piramal Enterprises, Pfizer, Colgate Palmolive India, Lupin and Intas Pharmaceuticals to name a few.

Business area of the company

Bajaj Healthcare is a pharmaceutical company with manufacturing and marketing capabilities in Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosage Formulations (FDFs) with focus on Vitamins, Amino Acids, Anti-Convulsants and Finished Dosage Forms (FDFs) caters to various therapeutic segments.

Major events

  • 1993-1994: Incorporated under Companies Act, 1956 as Bajaj Healthcare Private Limited by setting up plant at Tarapur.
  • 1996-1997: First Export Sale.
  • 2004-2005: Changed the status of the company from Private to Public i.e. to Bajaj Healthcare Limited.
  • 2005-2006: Purchase and Set-up a new facility at Salvi, Vadodara.
  • 2005-2006: Set up Corporate Office in Masjid Bunder.
  • 2006-2007: Purchase addition Plot N- 128 at Tarapur.
  • 2006-2007: Issued 20,00,000, Non- Cumulative Preference Shares of Rs 10 each.
  • 2006-2007: Major Term loan of Rs 863.00 lakhs was sanction and its total indebtedness reached to Rs 2,265 Lakh.
  • 2007-2008 Purchase and Set-up a new facility at Manjusar, Vadodara.
  • 2007-2008 Increase in Capacity of its major products like; 100% Vitamin C and its derivatives and 50% in Choline Bitartrate, etc.
  • 2009-2010: Launched own brands under Manjusar/ Medicare.
  • 2013-2014: Purchase and Set-up a new facility at Panoli, Ankleshwar.
  • 2013-2014: First GVK Agreement.
  • 2013-2014: First USV Agreement.
  • 2014-2015: Purchase and Set-up a Second facility at Tarapur, Maharashtra.
  • 2015-2016: Acquisition of premises for new Corporate Office in Thane and set-up of the same.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.